Asset-management market share is unusually powerful because it compounds twice.

First, net inflows bring new money into the AMC.

Second, investment appreciation compounds the existing AUM base.

If an AMC simultaneously wins new flows and owns assets that rise with markets, revenue can grow much faster than the number of new customer accounts.

The opposite is also true.

An AMC can report positive AUM growth while still losing market share if competitors attract more flows or own faster-growing asset categories.

This distinction is central to Nippon India versus UTI.

For Bull Run's company pages, see Nippon Life India Asset Management, UTI AMC and the Asset Management Company sector dashboard. Also see HDFC AMC vs Nippon Life India AMC for another large-AMC benchmark.

Q1 FY27 comparison

Nippon gained 54 basis points of overall market share in one year

Nippon India Mutual Fund QAAUM increased from roughly ₹6.1 lakh crore to ₹7.52 lakh crore.

Growth was approximately 23%.

The mutual-fund industry itself grew strongly, but Nippon grew faster.

Its market share therefore increased to 9.04%, up 54 basis points year on year and 15 basis points sequentially.

The company retained its rank as the fourth-largest AMC by total and equity QAAUM.

Management described Nippon as the fastest-growing top-ten AMC during Q1 FY27.

UTI grew AUM but still lost market share

UTI MF QAAUM increased 8.82% to ₹3.93 lakh crore.

That sounds respectable in isolation.

But the industry grew approximately 15%.

Because UTI grew materially slower than the market, overall share fell:

5.00% → 4.76% → 4.72%

from June 2025 to March 2026 to June 2026.

This is why AMC investors should always examine both AUM growth and market share.

The equity-market-share race is even more one-sided

Nippon's equity QAAUM grew around 22% to ₹3.51 lakh crore.

Its equity market share reached 7.38%.

UTI's equity QAAUM was essentially flat at ₹94,567 crore.

Its market share fell by 41 basis points to 2.60%.

This is economically important because active equity is usually a higher-fee asset category.

A market-share loss in equity can therefore hurt revenue more than an equivalent loss in low-fee institutional assets.

Nearly half of Nippon's MF AUM is equity

Equity represented approximately 46.7% of Nippon MF QAAUM.

UTI's separately disclosed pure-equity category represented approximately 24.1%.

If UTI's hybrid category is added as a rough broader growth-asset proxy, the share becomes approximately 32.7%.

The definitions remain different, so 46.7% versus 32.7% is not a company-reported apples-to-apples statistic.

Directionally, however, Nippon operates with a materially more equity-rich AUM mix.

Nippon is also winning in passive assets

The normal trade-off in the AMC sector is that one company is strong in active equity while another dominates passive products.

Nippon complicates that framework.

It is strong in both.

Nippon ETF QAAUM reached approximately ₹2.43 lakh crore, up 40% year on year.

ETF market share reached about 21.35%, up roughly 159 basis points.

UTI ETF and Index QAAUM reached approximately ₹1.80 lakh crore, up 15.87%.

UTI's category market share was 12.20%.

The category definitions are slightly different — Nippon's disclosure specifically highlights ETF QAAUM while UTI combines ETFs and index funds — but Nippon's current passive momentum is unmistakably stronger.

UTI's passive business is growing, but slower than the market

UTI passive QAAUM increased from approximately ₹1.55 lakh crore to ₹1.80 lakh crore.

That is healthy absolute growth.

Yet category market share declined from 13.18% to 12.20%.

The industry passive pool expanded even faster.

This creates an uncomfortable combination:

• UTI is losing active-equity share, and
• its historic passive strength is also experiencing relative share pressure.

The company needs stronger net sales rather than relying only on market appreciation.

Nippon's systematic-investment engine is a major advantage

Nippon reported Q1 systematic flows of approximately ₹11,030 crore, up 13% year on year.

The June monthly systematic book was around ₹3,720 crore.

Annualised, management described the systematic book at approximately ₹44,600 crore.

SIP market share was around 9.84%.

This is strategically valuable because Nippon's SIP flow share remains above its equity-AUM market share.

That creates a possible future market-share flywheel.

If new recurring equity flows enter at a higher market share than Nippon's existing equity asset share, future AUM share can continue rising even before market appreciation.

UTI's SIP book is durable but smaller

UTI reported SIP AUM of approximately ₹45,595 crore, up 8.05% year on year.

Monthly gross SIP inflows remained around the ₹800-crore range.

The company highlighted that most SIP mandates are long tenure, which improves stability.

UTI's challenge is not the absence of a SIP franchise.

It is that current flow scale is not large enough to prevent market-share erosion across the broader mutual-fund business.

Nippon's “systematic flows” and UTI's gross SIP measures should not be assumed to use identical definitions.

Investor reach: the definitions are different, but Nippon's scale is extraordinary

Nippon reported 24.1 million unique investors.

That represented approximately 39% of the mutual-fund industry's unique-investor base.

Total folios crossed 40 million.

In other words, more than one in three unique Indian mutual-fund investors had money with Nippon India Mutual Fund under the company's disclosed measure.

UTI reported approximately 14.2 million live folios.

A folio is not the same as a unique investor.

One investor can hold multiple folios.

The numbers therefore should not be ranked directly.

B30 penetration favours Nippon

Nippon reported B30 AUM of approximately ₹1.56 lakh crore, up 24% year on year.

B30 represented approximately 20.5% of NIMF AUM versus the industry around 18.5%.

UTI reported around 19% B30 monthly AUM, broadly in line with the industry.

B30 assets are strategically attractive because penetration remains lower outside India's top 30 cities and retail assets can be relatively sticky.

Nippon's distribution footprint supports that reach

Nippon reported:

• 271 locations,
• more than 1.25 lakh distributors,
• 40.2 million folios,
• 24.1 million unique investors,
• 78% of new purchase transactions through digital channels.

Digital purchase transactions increased 26% to 4.49 million during Q1.

The model combines physical reach with increasingly digital transaction behaviour.

UTI remains deeply distributed too

UTI's network included:

• 255 financial centres,
• 202 centres in B30 locations,
• approximately 99,276 mutual-fund distributors,
• presence in 699 districts,
• offices across several international financial centres.

The distribution infrastructure is therefore not the principal problem.

The question is product performance, flow conversion and share capture.

The operating-profit divergence is as important as the AUM divergence

Nippon's Q1 revenue from operations reached approximately ₹766.9 crore, up 26%.

Operating profit reached ₹494.3 crore, up 31%.

PAT reached a record ₹503.7 crore, up 27%.

UTI reported core revenue of approximately ₹379 crore, essentially flat year on year.

Core EBITDA was ₹178 crore, up 3%.

Core PAT was ₹129 crore, up 6%.

Nippon displayed textbook positive operating leverage

Operating revenue increased 26%.

Operating expenses increased approximately 19%.

Operating profit therefore increased 31%.

This is the operating leverage AMC investors want to see.

Once technology, investment teams, branch infrastructure and central functions are in place, incremental fee revenue should not require proportionally equal expense growth.

That is one reason successful AMCs can produce very high ROE without using financial leverage.

UTI's cost leverage improved sequentially, but revenue remains the bottleneck

UTI core EBITDA increased approximately 21% sequentially despite core revenue increasing only around 1%.

Core PAT increased roughly 31% sequentially.

That is encouraging.

But expense optimisation cannot compensate indefinitely for weak fee growth.

To create sustained operating leverage, UTI needs:

• higher equity net sales,
• better active-fund performance,
• stronger passive flow share,
• greater SIP acquisition,
• higher revenue per unit of AUM.

Revenue yield: Nippon has a modest mix advantage before cost leverage

Annualising Nippon's Q1 operating revenue against MF QAAUM gives an analytical revenue yield of approximately 41 basis points.

Annualising UTI's core revenue against MF QAAUM gives approximately 39 basis points.

The initial revenue-yield difference is not enormous.

The much larger difference appears after expenses.

Nippon's operating profit was approximately 64% of operating revenue.

UTI's core EBITDA was approximately 47% of core revenue.

The definitions differ — operating profit and core EBITDA are not identical accounting lines — but this still shows why operating leverage matters as much as AUM mix.

Valuation: the market already understands Nippon's quality

Nippon traded at approximately 73% higher P/E than UTI.

That premium is substantial.

But the operating gap is also substantial:

• QAAUM growth 23% versus 8.82%,
• market-share gain versus market-share loss,
• equity AUM +22% versus -0.34%,
• operating-profit growth +31% versus core EBITDA +3%,
• ROE in the mid-30s versus single digits in Bull Run's database.

A premium multiple can still be dangerous

The stronger company is not automatically the better-priced stock.

At nearly 47x earnings, Nippon needs strong growth to continue.

If AUM growth normalises to industry levels, ETF fees compress, equity flows slow or operating expenses accelerate, earnings growth can fall while the valuation multiple remains high.

That creates de-rating risk.

UTI begins with lower expectations.

At 27x earnings and a 4%+ dividend yield, even moderate improvement in active-equity flows could change the valuation debate.

UTI's low P/B reflects its lower ROE

UTI traded around 2.76x book while Nippon traded above 16x.

The gap looks extreme.

But book value is not a particularly useful standalone AMC valuation metric.

AMCs are asset-light businesses.

They do not need to hold shareholder capital equal to customer AUM.

A company earning 30%+ ROE can rationally command a very high P/B multiple.

A company producing single-digit ROE should trade at a much smaller one.

The more useful valuation framework combines P/E with:

• AUM growth,
• fee yield,
• equity mix,
• market-share direction,
• operating margin,
• ROE.

Stock-market snapshot

The stock market had already rewarded Nippon's superior operating momentum.

Its shares were up more than 45% over the prior year and traded close to the 52-week high.

UTI was down almost 34% and traded near its 52-week low.

This is important for forward-looking investors because strong fundamentals and attractive entry valuation are not always found in the same company.

Which AMC has better AUM growth?

Nippon Life India AMC by a wide margin.

MF QAAUM grew 23% versus UTI at 8.82%.

Nippon also gained market share while UTI lost it.

Which has the stronger equity franchise?

Nippon Life India AMC.

Equity QAAUM reached ₹3.51 lakh crore and market share was 7.38%.

UTI equity QAAUM was ₹94,567 crore and share fell to 2.60%.

Which has the stronger passive franchise?

Nippon currently leads on scale and growth, although UTI remains a major passive competitor.

Nippon ETF QAAUM was approximately ₹2.43 lakh crore and grew 40%.

UTI ETF and index QAAUM was ₹1.80 lakh crore and grew 15.87%.

The categories are not perfectly identical because UTI combines ETFs and index funds.

Which is cheaper?

UTI AMC.

Its 27x P/E is far below Nippon's 46.7x and its dividend yield is more than twice as high.

The discount reflects slower growth, weaker market-share trends and lower profitability.

Nippon Life India AMC vs UTI AMC: category-by-category

Which is stronger in 2026?

Nippon Life India AMC currently has the substantially stronger operating franchise.

It is:

• larger,
• growing faster,
• gaining market share,
• gaining equity share,
• growing ETFs faster,
• generating stronger operating leverage,
• producing much higher ROE.

UTI AMC's advantage is valuation and optionality from a low base.

If active-equity fund performance improves, net sales recover and core revenue begins compounding again, the current discount could narrow.

But at present that is a turnaround case rather than evidence already visible in the Q1 numbers.

What would justify Nippon's premium valuation?

• MF QAAUM growth staying above industry growth.
• Overall market share continuing to rise.
• Equity market share remaining above 7% and improving.
• ETF market share staying above 20%.
• Systematic flows remaining above existing AUM market share.
• Operating profit continuing to grow faster than revenue.
• ROE remaining above 30%.

What would make UTI's discount more interesting?

• Equity net sales turning consistently positive.
• Equity market share stabilising above 2.5% before recovering.
• Passive market share returning toward prior levels.
• Core revenue moving from flat to high-single-digit growth.
• Core EBITDA margin expanding without cutting growth investment.
• SIP flow market share increasing.
• ROE moving materially above current single-digit levels.

Frequently asked questions